ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00726388
Recruitment Status : Unknown
Verified April 2009 by Javelin Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : July 31, 2008
Last Update Posted : April 21, 2009
Sponsor:
Information provided by:
Javelin Pharmaceuticals

Brief Summary:
This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.

Condition or disease Intervention/treatment Phase
Pain, Postoperative Drug: DIC075V (intravenous diclofenac sodium) Phase 3

Detailed Description:
This is an open-label, multiple-dose, multiple-day, single-arm safety study of repeat-doses of DIC075V in patients with acute post-operative pain following abdominal (i.e., non-laparoscopic abdominal surgeries) or orthopedic (e.g., hip or knee joint replacement) surgery. Eligible patients will receive DIC075V IV bolus q6 hours. Safety assessments will be collected at baseline (immediately prior to starting DIC075V therapy) and at study discharge or early termination.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 850 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain
Study Start Date : September 2008
Estimated Primary Completion Date : April 2009
Estimated Study Completion Date : May 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: A
IV administration of multiple doses of DIC075V (intravenous diclofenac sodium) over multiple days
Drug: DIC075V (intravenous diclofenac sodium)
multiple doses up to 5 days



Primary Outcome Measures :
  1. Adverse Events [ Time Frame: 30 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • abdominal ( non-laparoscopic abdominal surgeries) or orthopedic ( hip or knee joint replacement) surgery or other surgeries requiring multiple doses of parenterally administered NSAIDs over multiple days
  • Expected stay > 48 hrs

Exclusion Criteria:

  • bilirubin > 2.5 mg/dl
  • prothrombin time is > 20% above the upper limit of normal
  • serum creatinine is > 1.9 mg/dl at screening.
  • known allergy or hypersensitivity to diclofenac, other NSAIDs,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00726388


  Show 46 Study Locations
Sponsors and Collaborators
Javelin Pharmaceuticals
Investigators
Study Director: Javelin Pharmaceuticals Javelin Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Javelin Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00726388     History of Changes
Other Study ID Numbers: DFC-010
First Posted: July 31, 2008    Key Record Dates
Last Update Posted: April 21, 2009
Last Verified: April 2009

Keywords provided by Javelin Pharmaceuticals:
safety
diclofenac
pain, postoperative

Additional relevant MeSH terms:
Pain, Postoperative
Pain
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Diclofenac
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action